ELTX
Price
$9.34
Change
+$0.04 (+0.43%)
Updated
Jul 18 closing price
Capitalization
149.41M
NTLA
Price
$12.06
Change
+$0.23 (+1.94%)
Updated
Jul 18 closing price
Capitalization
1.25B
11 days until earnings call
Interact to see
Advertisement

ELTX vs NTLA

Header iconELTX vs NTLA Comparison
Open Charts ELTX vs NTLABanner chart's image
Elicio Therapeutics
Price$9.34
Change+$0.04 (+0.43%)
Volume$50.23K
Capitalization149.41M
Intellia Therapeutics
Price$12.06
Change+$0.23 (+1.94%)
Volume$3.84M
Capitalization1.25B
ELTX vs NTLA Comparison Chart in %
Loading...
ELTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELTX vs. NTLA commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELTX is a Hold and NTLA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (ELTX: $9.30 vs. NTLA: $12.06)
Brand notoriety: ELTX and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELTX: 103% vs. NTLA: 77%
Market capitalization -- ELTX: $149.41M vs. NTLA: $1.25B
ELTX [@Biotechnology] is valued at $149.41M. NTLA’s [@Biotechnology] market capitalization is $1.25B. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELTX’s FA Score shows that 1 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • ELTX’s FA Score: 1 green, 4 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ELTX and NTLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELTX’s TA Score shows that 5 TA indicator(s) are bullish while NTLA’s TA Score has 5 bullish TA indicator(s).

  • ELTX’s TA Score: 5 bullish, 4 bearish.
  • NTLA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ELTX and NTLA are a good buy in the short-term.

Price Growth

ELTX (@Biotechnology) experienced а +15.10% price change this week, while NTLA (@Biotechnology) price change was +4.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

NTLA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($1.25B) has a higher market cap than ELTX($149M). ELTX YTD gains are higher at: 82.353 vs. NTLA (3.431). ELTX has higher annual earnings (EBITDA): -49.52M vs. NTLA (-530.8M). NTLA has more cash in the bank: 504M vs. ELTX (18.4M). ELTX has less debt than NTLA: ELTX (5.79M) vs NTLA (119M). NTLA has higher revenues than ELTX: NTLA (45.6M) vs ELTX (0).
ELTXNTLAELTX / NTLA
Capitalization149M1.25B12%
EBITDA-49.52M-530.8M9%
Gain YTD82.3533.4312,401%
P/E Ratio5.96N/A-
Revenue045.6M-
Total Cash18.4M504M4%
Total Debt5.79M119M5%
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELTXNTLA
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 5 days ago
72%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 5 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 11 days ago
77%
Declines
ODDS (%)
Bearish Trend 10 days ago
88%
Bearish Trend 21 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ELTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HILFX35.370.22
+0.63%
Hennessy Large Cap Financial Instl
VCGRX23.590.01
+0.04%
Virtus KAR Capital Growth R6
BWLRX24.49-0.04
-0.16%
American Beacon Man Lg Cp Value R6
DIAMX28.42-0.05
-0.18%
Diamond Hill Long-Short Inv
VENAX60.41-0.31
-0.51%
Vanguard Energy Index Admiral

ELTX and

Correlation & Price change

A.I.dvisor tells us that ELTX and PCVX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ELTX and PCVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELTX
1D Price
Change %
ELTX100%
N/A
PCVX - ELTX
30%
Poorly correlated
-0.98%
OBIO - ELTX
30%
Poorly correlated
-2.52%
CORT - ELTX
29%
Poorly correlated
-3.06%
NTLA - ELTX
28%
Poorly correlated
+1.94%
HNSBF - ELTX
27%
Poorly correlated
N/A
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with CRSP. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+1.94%
CRSP - NTLA
67%
Closely correlated
+18.22%
BEAM - NTLA
63%
Loosely correlated
+1.47%
RXRX - NTLA
57%
Loosely correlated
+5.80%
ABCL - NTLA
55%
Loosely correlated
+14.62%
IDYA - NTLA
55%
Loosely correlated
-2.26%
More